Xiamen Amoytop Biotech Co., Ltd. Stock: price and insider trades · China
特宝生物
Xiamen Amoytop Biotech Co., Ltd.: what insiders have been doing
Xiamen Amoytop Biotech Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). No insider at Xiamen Amoytop Biotech Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 15 July 2024.
Looking back to 2021, when coverage begins, insiders filed no purchases and 5 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 190,000 shares100.0% of flowA股XSHGSSE:173000007846811460
- 106,904 shares39.6% of flowA股XSHGSSE:173000004568870750
- 130,691 shares48.1% of flowA股XSHGSSE:173000004566260670
- 5,302 shares1.5% of flowA股XSHGSSE:173000004438404300
- 37,791 shares10.8% of flowA股XSHGSSE:173000004438404830
5 of 5 declarations
About Xiamen Amoytop Biotech Co., Ltd.
特宝生物 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of biopharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
